Skip to Content

Driehaus Micro Cap Growth DMCRX

Medalist Rating as of | See Driehaus Investment Hub
  • NAV / 1-Day Return 11.52  /  −1.20 %
  • Total Assets 240.4 Mil
  • Adj. Expense Ratio
    1.420%
  • Expense Ratio 1.420%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Small Growth
  • Investment Style Small Growth
  • Min. Initial Investment 10,000
  • Status Limited
  • TTM Yield 0.77%
  • Turnover 128%

USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 12:05 AM GMT+0

Morningstar’s Analysis DMCRX

Will DMCRX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin Driehaus Micro Cap Growth's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings DMCRX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 20.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Modine Manufacturing Co

3.10 7.5 Mil
Consumer Cyclical

Crinetics Pharmaceuticals Inc

2.70 6.5 Mil
Healthcare

Camtek Ltd

2.40 5.8 Mil
Technology

Xenon Pharmaceuticals Inc

2.19 5.3 Mil
Healthcare

FTAI Aviation Ltd

1.94 4.7 Mil
Industrials

Sterling Infrastructure Inc

1.81 4.4 Mil
Industrials

Rhythm Pharmaceuticals Inc

1.63 3.9 Mil
Healthcare

Vaxcyte Inc Ordinary Shares

1.54 3.7 Mil
Healthcare

Uranium Energy Corp

1.52 3.7 Mil
Energy

Blue Bird Corp

1.48 3.6 Mil
Consumer Cyclical